X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6755) 6755
Publication (887) 887
Newsletter (138) 138
Book Review (32) 32
Book Chapter (22) 22
Newspaper Article (16) 16
Magazine Article (10) 10
Dissertation (5) 5
Conference Proceeding (3) 3
Web Resource (3) 3
Paper (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3921) 3921
ceftazidime (3404) 3404
microbiology (1925) 1925
male (1862) 1862
female (1819) 1819
pharmacology & pharmacy (1659) 1659
microbial sensitivity tests (1567) 1567
index medicus (1499) 1499
ceftazidime - pharmacology (1465) 1465
ceftazidime - therapeutic use (1397) 1397
infectious diseases (1389) 1389
adult (1264) 1264
anti-bacterial agents - pharmacology (1254) 1254
middle aged (1214) 1214
antibiotics (1078) 1078
anti-bacterial agents - therapeutic use (1044) 1044
aged (972) 972
infections (724) 724
pseudomonas aeruginosa - drug effects (721) 721
ceftazidime - administration & dosage (694) 694
adolescent (673) 673
cephalosporins - pharmacology (653) 653
resistance (572) 572
animals (557) 557
cephalosporins - therapeutic use (535) 535
bacteria (518) 518
beta-lactamases - metabolism (517) 517
child (508) 508
beta-lactamases - genetics (505) 505
bacterial infections - drug therapy (500) 500
anti-bacterial agents - administration & dosage (496) 496
escherichia-coli (481) 481
pseudomonas aeruginosa (480) 480
treatment outcome (479) 479
pseudomonas infections - drug therapy (473) 473
drug therapy, combination (457) 457
cefepime (441) 441
pseudomonas-aeruginosa (438) 438
drug resistance, microbial (435) 435
cephalosporins (432) 432
enterobacteriaceae (421) 421
ciprofloxacin (398) 398
pharmacokinetics (398) 398
prospective studies (394) 394
imipenem (387) 387
research article (387) 387
therapy (385) 385
aged, 80 and over (376) 376
meropenem (374) 374
klebsiella-pneumoniae (372) 372
escherichia coli - drug effects (361) 361
drug resistance (349) 349
child, preschool (344) 344
biochemical phenomena, metabolism, and nutrition (342) 342
cefotaxime (337) 337
immunology (329) 329
research (323) 323
infection (322) 322
ceftazidime - pharmacokinetics (321) 321
oncology (320) 320
gram-negative bacteria (313) 313
fever (302) 302
epidemiology (299) 299
gram-negative bacteria - drug effects (298) 298
antimicrobial agents (293) 293
pneumonia (288) 288
infant (287) 287
polycyclic compounds (287) 287
amikacin (286) 286
susceptibility (285) 285
ceftazidime - adverse effects (284) 284
health aspects (284) 284
klebsiella pneumoniae - drug effects (284) 284
bacterial infections and mycoses (276) 276
drug resistance, bacterial (268) 268
risk factors (268) 268
cefotaxime - pharmacology (267) 267
hospitals (265) 265
anti-bacterial agents - pharmacokinetics (262) 262
drug therapy, combination - therapeutic use (262) 262
enterobacteriaceae - drug effects (261) 261
pediatrics (260) 260
kinetics (256) 256
ceftriaxone (254) 254
gentamicin (254) 254
pseudomonas infections - microbiology (252) 252
ceftazidime-avibactam (248) 248
vancomycin (248) 248
bacteremia (247) 247
antimicrobial resistance (246) 246
imipenem - pharmacology (244) 244
infusions, intravenous (244) 244
retrospective studies (242) 242
bacteria - drug effects (240) 240
cephalosporins - administration & dosage (238) 238
drug resistance in microorganisms (238) 238
medicine, general & internal (238) 238
strains (228) 228
time factors (227) 227
antibiotic resistance (225) 225
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6258) 6258
French (214) 214
Japanese (131) 131
Spanish (66) 66
German (62) 62
Chinese (56) 56
Italian (56) 56
Russian (31) 31
Polish (21) 21
Turkish (19) 19
Romanian (6) 6
Croatian (5) 5
Czech (5) 5
Hungarian (4) 4
Korean (4) 4
Portuguese (4) 4
Slovak (3) 3
Danish (2) 2
Dutch (2) 2
Lithuanian (2) 2
Arabic (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Finnish (1) 1
Indonesian (1) 1
Persian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Antimicrobial Agents, ISSN 0924-8579, 04/2010, Volume 35, Issue 4, pp. 412 - 413
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 06/2016, Volume 62, Issue 11, pp. 1380 - 1389
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 09/2016, Volume 63, Issue 6, pp. 754 - 762
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2018, Volume 62, Issue 8
Journal Article
Future Microbiology, ISSN 1746-0913, 06/2017, Volume 12, Issue 8, pp. 655 - 670
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 03/2014, Volume 54, Issue 3, pp. 331 - 340
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 11/2018, Volume 61, Issue 22, pp. 10340 - 10344
Only one FDA-approved beta-lactamase inhibitor has ever been orally available: clavulanic acid, approved in 1984. Avibactam, approved by FDA in 2015, is the... 
CEFTAZIDIME-AVIBACTAM | CHEMISTRY, MEDICINAL | DIAZABICYCLOOCTANES
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2017, Volume 61, Issue 2
Journal Article
Infection, ISSN 0300-8126, 10/2018, Volume 46, Issue 5, pp. 721 - 724
The emergence of carbapenemase-producing Klebsiella pneumonia (KPC-Kp) has become a significant problem in terms of public health and clinical outcome in many... 
Ceftazidime–avibactam | Medicine & Public Health | Procalcitonin | Endocarditis | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Thrombophlebitis | Klebsiella pneumoniae | INFECTIOUS DISEASES | IMPACT | BACTEREMIA | INFECTIVE ENDOCARDITIS | SPREAD | Ceftazidime-avibactam | ENTEROBACTERIACEAE | Azabicyclo Compounds - pharmacology | Endocarditis, Bacterial - etiology | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Thrombophlebitis - drug therapy | beta-Lactamases - genetics | Klebsiella pneumoniae - genetics | Thrombophlebitis - diagnosis | Azabicyclo Compounds - therapeutic use | Endocarditis, Bacterial - drug therapy | Klebsiella Infections - drug therapy | Bacterial Proteins - genetics | Endocarditis, Bacterial - diagnosis | Treatment Outcome | Klebsiella Infections - complications | Klebsiella Infections - microbiology | Bacteremia | Biomarkers | Klebsiella Infections - diagnosis | Thrombophlebitis - etiology | Ceftazidime - therapeutic use | Drug Combinations | Klebsiella | Complications and side effects | Causes of | Physiological aspects | Dosage and administration | Research | Drug therapy | Ceftazidime | Cardiovascular system | Therapy | Pneumonia | Medical services | Carbapenemase | Cultures | Infections | Ertapenem | Patients | Blood | Metastases | Lungs | Abscesses | Public health
Journal Article